Abu Dhabi
Primary Location

Abu Dhabi


About Rakesh Suri, M.D., D.Phil.

Rakesh Suri, MD, is Chief Executive Officer and Chair of Thoracic and Cardiovascular Surgery at Cleveland Clinic Abu Dhabi. In his role, Dr. Suri oversees the hospital’s overall strategy and effective operation as the first-ever U.S. multispecialty hospital to be replicated outside of North America with more than 5,000 caregivers.

He is also a consultant in the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic in the U.S. and Professor of Surgery at Cleveland Clinic Lerner College of Medicine. Dr. Suri came to Cleveland Clinic from Mayo Clinic, where he served as a consultant in the Division of Cardiovascular Surgery, Professor of Surgery, and Chair of the Enterprise Robotic Practice, among other education- and innovation-oriented roles.

He was named Chief of Staff at Cleveland Clinic Abu Dhabi in 2015, where he led the recruitment of more than 400 world-class physicians, participated in the opening and initiation of clinical services throughout the hospital and led the medical staff to deliver a suite of complex and innovative services with safety and quality outcomes that are competitive among leading academic medical centers globally.

In his secondary role, Dr. Suri recruited and led the Cardiovascular and Thoracic Surgical team, and was involved in the creation of robotic and transcatheter cardiac programs at Cleveland Clinic Abu Dhabi.

Dr. Suri brings a commitment to his patients and surgical innovation, a passion for research and an enthusiasm for teaching others. He holds extensive clinical expertise in robotic and minimally invasive cardiac surgery, mitral valve repair and transcatheter valve therapies.

He has completed more than 6,000 surgical procedures in his career and helped make Cleveland Clinic Abu Dhabi home to the most sophisticated group of robotic cardiac surgeons in the world.

His significant research pursuits include contributions to more than 320 peer-reviewed journal articles and book chapters, 17 patents and several FDA multicenter trials. He has led and participated in cutting-edge clinical trials during his time at Cleveland Clinic Abu Dhabi and Cleveland Clinic.

Dr. Suri earned his undergraduate degree at Queen’s University in Kingston, Canada, medical degree with honors from the University of Toronto and a doctorate at Magdalen College, Oxford, UK, as a Rhodes Scholar. He trained in General Surgery and performed a Cardiovascular Surgery fellowship at the University of Toronto. He completed a Thoracic Surgical Residency at Mayo College of Medicine.

Dr. Suri and his wife, Brook, reside in Abu Dhabi with their two children.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Residency - Mayo Clinic
Thoracic Surgery
Rochester, MN USA

Fellowship - Saint Michael's Hospital
Cardiac Surgery
Toronto, ON Canada

Residency - University of Toronto Hospitals
General Surgery
Toronto, Ontario, Canada,

Medical Education - Magdalen College

Medical Education - University of Toronto Faculty of Medicine

Undergraduate - Queens University
Kingston, Ontario,


  • General Surgery
  • Cardiac Surgery
  • Thoracic Surgery - Thoracic and Cardiac Surgery
Research & Publications

Research & Publications

See publications for Rakesh Suri, M.D., D.Phil..

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/14/2020, Dr. Suri has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring Rakesh Suri, M.D., D.Phil.

Related Videos Featuring Rakesh Suri, M.D., D.Phil.

Back to Top